Prediction of multiple infections after severe burn trauma: A prospective cohort study

Annals of Surgery

Volumn 261, Issue 4, 2015, Pages 781-792

  Yan, Shuangchun ^a,b,c   Tsurumi, Amy ^a,b,c   Que, Yok Ai ^d   Ryan, Colleen M ^a,c   Bandyopadhaya, Arunava ^a,b,c   Morgan, Alexander A ^e   Flaherty, Patrick J ^f,g   Tompkins, Ronald G ^a   Rahme, Laurence G ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Worcester Polytechnic Institute   (United States)

^g WORCESTER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Burn; Genomics; Infection; Predictive Models; Prognosis; Sepsis; Trauma

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT; HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTOME; HISTONE;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BODY MASS; BODY SURFACE; BURN; BURN INFECTION; BURN PATIENT; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN REGULATION; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC MODEL; HISTONE ACETYLATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INTRACELLULAR SIGNALING; LENGTH OF STAY; LEUKOCYTE MIGRATION; LUNG BURN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PNEUMONIA; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; UPREGULATION; AREA UNDER THE CURVE; BACTERIAL INFECTIONS; BODY WEIGHT; BURNS; BURNS, INHALATION; CASE CONTROL STUDY; COMORBIDITY; CROSS INFECTION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INJURY SCALE; OBESITY; OVERWEIGHT; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL MODEL; WNT SIGNALING PATHWAY;

ADULT; APACHE; AREA UNDER CURVE; BACTERIAL INFECTIONS; BURNS; BURNS, INHALATION; CASE-CONTROL STUDIES; CHROMATIN ASSEMBLY AND DISASSEMBLY; COHORT STUDIES; COMORBIDITY; CROSS INFECTION; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; INJURY SEVERITY SCORE; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; OBESITY; OVERWEIGHT; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; ROC CURVE; T-LYMPHOCYTES; THINNESS; TRANSCRIPTOME; WNT SIGNALING PATHWAY;

EID: 84988487610     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000759     Document Type: Article

References (57)

1. Morris JA,MacKenzie EJ, DamianoAM, et al.Mortality in trauma patients: the interaction between host factors and severity. J Trauma. 1990;30:1476-1482.
2. Kraft R, Herndon DN, Al-Mousawi AM, et al. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet. 2012;379:1013-1021.
3. Ryan CM, Schoenfeld DA, Thorpe WP, et al. Objective estimates of the probability of death from burn injuries. N Engl J Med. 1998;338:362-366.
4. Osler T, Glance L, Buzas JS, et al. A trauma mortality prediction model based on the anatomic injury scale. Ann Surg. 2008;247:1041-1048.
5. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med. 2006;354:366-378.
6. Church D, Elsayed S, Reid O, et al. Burn wound infections. Clin Microbiol Rev. 2006;19:403-434.
7. Bloemsma GC, Dokter J, Boxma H, et al. Mortality and causes of death in a burn centre. Burns. 2008;34:1103-1107.
8. Ingraham AM, Xiong W, Hemmila MR, et al. The attributable mortality and length of stay of trauma-related complications: a matched cohort study. Ann Surg. 2010;252:358-362.
9. Kesarwani M, Hazan R, He J, et al. A quorum sensing regulated small volatile molecule reduces acute virulence and promotes chronic infection phenotypes. PLoS Pathog. 2011;7:e1002192.
10. Bandyopadhaya A, Kesarwani M, Que Y-A, et al. The quorum sensing volatile molecule 2-amino acetophenon modulates host immune responses in a manner that promotes life with unwanted guests. PLoS Pathog. 2012;8:e1003024.
11. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12.
12. Avni T, Levcovich A, Ad-El DD, et al. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010;340:c241.
13. Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug resistance. Cell Host Microbe. 2013;13:632-642.
14. Pirnay J-P, DeVosD,CochezC, et al. Molecular epidemiology of pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol. 2003;41:1192-1202.
15. De Vos D, Lim AJ, Pirnay P, et al. Analysis of epidemic Pseudomonas aeruginosa isolates by isoelectric focusing of pyoverdine and RAPD-PCR: modern tools for an integrated anti-nosocomial infection strategy in burn wound centres. Burns. 1997;23:379-386.
16. Brunkhorst FM, Oppert M, Marx G, et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA. 2012;307:2390-2399.
17. Schuetz P, LitkeA,Albrich WC, et al. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26:159-167.
18. Härtel C, Deuster M, Lehrnbecher T, et al. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer. 2007;49:767-773.
19. Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA. 2011;306:2614-2615.
20. Kuehn BM. Guideline promotes early, aggressive sepsis treatment to boost survival. JAMA. 2013;309:969-970.
21. Schuetz P, Haubitz S, Mueller B. Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care? Curr Opin Crit Care. 2012;18:341-349.
22. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-851.
23. Nichols RL, Smith JW, Klein DB, et al. Risk of infection after penetrating abdominal trauma. N Engl J Med. 1984;311:1065-1070.
24. Kisat M, Villegas CV, Onguti S, et al. Predictors of sepsis in moderately severely injured patients: an analysis of the national trauma data bank. Surg Infect (Larchmt). 2013;14:62-68.
25. Wibbenmeyer L, Danks R, Faucher L, et al. Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Care Res. 2006;27:152-160.
26. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594-2605.
27. Lavrentieva A, Papadopoulou S, Kioumis J, et al. PCT as a diagnostic and prognostic tool in burn patients: whether time course has a role in monitoring sepsis treatment. Burns. 2012;38:356-363.
28. Schultz L, Walker SAN, Elligsen M, et al. Identification of predictors of early infection in acute burn patients. Burns. 2013;39:1355-1366.
29. Cuenca AG, Gentile LF, Lopez MC, et al. Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Crit Care Med. 2013;41:1175-1185.
30. Laudanski K, Miller-Graziano C, Xiao W, et al. Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A. 2006;103: 15564-15569.
31. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J ExpMed. 2011;208:2581-2590.
32. Jeschke MG, Finnerty CC, Emdad F, et al. Mild obesity is protective after severe burn injury. Ann Surg. 2013;258:1119-1129.
33. Wu Z, Irizarry RA, Gentleman R, et al. A Model Based Background Adjustment for Oligonucleotide Expression Arrays. Baltimore, MD: Johns Hopkins University, Department of Biostatistics Working Papers; 2004.
34. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
35. Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics-A bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25:415-416.
36. Servant N, Gravier E, Gestraud P, et al. EMA: a R package for easy microarray data analysis. BMC Res Notes. 2010;3:277.
37. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article 3.
38. Huang DW, Sherman BT, Stephens R, et al. DAVID gene ID conversion tool. Bioinformation. 2008;2:428-430.
39. Tibshirani R. Regression Shrinkage and Selection via the Lasso. J R Stat Soc Series B Stat Methodol. 1996;58:267-288.
40. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1-22.
41. Wacharasint P, Boyd JH, Russell JA, et al. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17:R122.
42. Johnson CA, Kleshchenko YY, Ikejiani AO, et al. Thrombospondin-1 interacts with trypanosoma cruzi surface calreticulin to enhance cellular infection. PLoS One. 2012;7:e40614.
43. McMaken S, Exline MC, Mehta P, et al. Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity. PLoS One. 2011;6:e19654.
44. Streit M, Velasco P, Riccardi L, et al. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 2000;19:3272-3282.
45. Shannon O. Platelets interact with bacterial pathogens. Thromb Haemost. 2009;102:613-614.
46. Carson WF, Cavassani KA, Dou Y, et al. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics. 2011;6:273-283.
47. Smale ST. Selective transcription in response to an inflammatory stimulus. Cell. 2010;140:833-844.
48. Perez-Campo FM, Costa G, Lie-a-Ling M, et al. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis. Immunology. 2013;139:161-165.
49. De Santa F, Narang V, Yap ZH, et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 2009;28:3341-3352.
50. Kruidenier L, Chung C-W, Cheng Z, et al.Aselective jumonjiH3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488:404-408.
51. Netea MG,Wijmenga C, O'Neill LAJ. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol. 2012;13:535-542.
52. Bronkhorst MW, Lomax MA, Vossen RH, et al. Risk of infection and sepsis in severely injured patients related to single nucleotide polymorphisms in the lectin pathway. Br J Surg. 2013;100:1818-1826.
53. Jannes G, De Vos D. A review of current and future molecular diagnostic tests for use in the microbiology laboratory. Methods Mol Biol. 2006;345: 1-21.
54. Pirnay J-P, De Vos D, Duinslaeger L, et al. Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'realtime' polymerase chain reaction. Crit Care. 2000;4:255.
55. Chang S-S,HsiehW-H, Liu T-S, et al. Multiplex PCRsystem for rapid detection of pathogens in patients with presumed sepsis: a systemic review and metaanalysis. PLoS One. 2013;8:e62323.
56. Skvarc M, Stubljar D, Rogina P, et al. Non-culture-based methods to diagnose bloodstream infection: does it work? Eur J Microbiol Immunol (Bp). 2013;3:97-104.
57. Apidianakis Y, Que YA, Xu W, et al. Down-regulation of glutathione S-transferase 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J. 2012;26:730-737.